|
Research Management and Support
|
RMS2010 [E]
|
$345,370,533
|
$26,989
|
N/A
|
National Cancer Institute
|
|
Training Program in Cancer Biology
|
5T32CA078207-12
|
$634,594
|
$209,416
|
AARONSON, STUART
|
MOUNT SINAI SCHOOL OF MEDICINE
|
|
Children's Oncology Group Chair's Grant
|
5U10CA098543-08
|
$26,966,030
|
$17,258,259
|
ADAMSON, PETER
|
NATIONAL CHILDHOOD CANCER FOUNDATION
|
|
Mechanisms of T cell leukemia induction and maintenance
|
1R01CA149655-01
|
$350,675
|
$350,675
|
AIFANTIS, IANNIS
|
NEW YORK UNIVERSITY SCHOOL OF MEDICINE
|
|
Modifiers of Notch stability and their role in cancer
|
1R21CA141399-01A2
|
$220,545
|
$220,545
|
AIFANTIS, IANNIS
|
NEW YORK UNIVERSITY SCHOOL OF MEDICINE
|
|
Regulation of hematopoietic stem cell differentiation
|
2R01CA105129-05A1
|
$308,858
|
$308,858
|
AIFANTIS, IANNIS
|
NEW YORK UNIVERSITY SCHOOL OF MEDICINE
|
|
The role of the SCF/FBW7 ubiquitin ligase complex in hematopiesis and leukemia
|
5R01CA133379-02
|
$351,713
|
$351,713
|
AIFANTIS, IANNIS
|
NEW YORK UNIVERSITY SCHOOL OF MEDICINE
|
|
Participation in the Eastern Cooperative Oncology Group
|
2U10CA107868-07
|
$235,766
|
$2,358
|
AISNER, JOSEPH
|
UNIV OF MED/DENT NJ-R W JOHNSON MED SCH
|
|
Prospective study of farmers and their families (Agricultural health study)
|
ZIA CP010119 02020
|
$1,832,019
|
$183,202
|
Alavanja, Michael
|
DCEG (NCI)
|
|
Agricultural Health Study - Biomarkers of Exposures and Effects in Agriculture
|
ZIA CP010119 10527
|
$143,853
|
$71,926
|
Alavanja, Michael
|
DCEG (NCI)
|
|
ATBC Study
|
ZIA CP010195 03031
|
$853,810
|
$25,614
|
Albanes, Demetrius
|
DCEG (NCI)
|
|
Arizona Cancer Center-Cancer Center Support Grant
|
3P30CA023074-32S1
|
$100,000
|
$2,000
|
Alberts, David
|
UNIVERSITY OF ARIZONA
|
|
Arizona Cancer Center-Cancer Center Support Grant
|
3P30CA023074-32S2
|
$143,893
|
$2,878
|
Alberts, David
|
UNIVERSITY OF ARIZONA
|
|
Arizona Cancer Center-Cancer Center Support Grant
|
3P30CA023074-32S3
|
$100,000
|
$2,000
|
Alberts, David
|
UNIVERSITY OF ARIZONA
|
|
Arizona Cancer Center-Cancer Center Support Grant
|
5P30CA023074-32
|
$4,161,905
|
$83,238
|
Alberts, David
|
UNIVERSITY OF ARIZONA
|
|
Cdk-2 Independent role of cyclin E in Cell survival
|
5R01CA127264-02
|
$325,302
|
$325,302
|
Almasan, Alexandru
|
CLEVELAND CLINIC LERNER COL/MED-CWRU
|
|
Inherited bone marrow failure syndromes study
|
ZIA CP010144 07130
|
$1,589,054
|
$556,169
|
Alter, Blanche
|
DCEG (NCI)
|
|
Rational Design and Clinical Development of Shepherdin: A Novel Anti-Cancer Agent
|
5R01CA118005-02
|
$341,338
|
$112,642
|
Altieri, Dario
|
UNIV OF MASSACHUSETTS MED SCH WORCESTER
|
|
Exploiting altered glucose utilization in Bcr-Abl+ Leukemia
|
1F31CA157166-01
|
$28,740
|
$28,740
|
Alvarez-Calderon, Francesca
|
UNIVERSITY OF COLORADO DENVER
|
|
Children's Oncology Group Statistics and Data Center Grant
|
3U10CA098413-08S1
|
$1,499,003
|
$959,362
|
ANDERSON, JAMES
|
NATIONAL CHILDHOOD CANCER FOUNDATION
|
|
Children's Oncology Group Statistics and Data Center Grant
|
3U10CA098413-08S2
|
$39,636
|
$25,367
|
ANDERSON, JAMES
|
NATIONAL CHILDHOOD CANCER FOUNDATION
|
|
Children's Oncology Group Statistics and Data Center Grant
|
3U10CA098413-08S3
|
$39,636
|
$25,367
|
ANDERSON, JAMES
|
NATIONAL CHILDHOOD CANCER FOUNDATION
|
|
Children's Oncology Group Statistics and Data Center Grant
|
5U10CA098413-08
|
$5,935,261
|
$3,798,567
|
ANDERSON, JAMES
|
NATIONAL CHILDHOOD CANCER FOUNDATION
|
|
Molecular Studies of Cellular Cytotoxicity
|
ZIA BC 010013
|
$644,596
|
$644,596
|
Anderson, Stephen
|
CCR (NCI)
|
|
Sweden and Denmark linked registries on hospital discharges and subsequent cancer
|
ZIA CP010183 00560
|
$113,406
|
$11,341
|
Anderson, William
|
DCEG (NCI)
|
|
Combined inhibition of CXCR4 and FLT3-ITD signaling in acute myeloid leukemia
|
1R21CA143805-01A1
|
$336,397
|
$336,397
|
ANDREEFF, MICHAEL
|
UNIVERSITY OF TEXAS MD ANDERSON CAN CTR
|
|
THE THERAPY OF AML
|
5P01CA055164-18
|
$2,483,417
|
$2,483,417
|
ANDREEFF, MICHAEL
|
UNIVERSITY OF TEXAS MD ANDERSON CAN CTR
|
|
Targeting Leukemia causing oncogene E2a-Pbx1 with synthetic molecules
|
5R01CA133508-03
|
$304,917
|
$304,917
|
ANSARI, ASEEM
|
UNIVERSITY OF WISCONSIN MADISON
|
|
Mechanisms of GVHD
|
5P01CA142106-07
|
$1,916,255
|
$689,852
|
ANTIN, JOSEPH
|
DANA-FARBER CANCER INSTITUTE
|
|
Collaborative Pathways that Lead to Leukemia
|
ZIA BC 010982
|
$289,223
|
$289,223
|
Aplan, Peter
|
CCR (NCI)
|
|
Pre-clinical Studies of Therapy for Myelodysplastic Syndrome
|
ZIA BC 010983
|
$289,223
|
$289,223
|
Aplan, Peter
|
CCR (NCI)
|
|
Activation of Proto-Oncogenes by Chromosomal Translocation
|
ZIA SC 010378
|
$289,223
|
$144,612
|
Aplan, Peter
|
CCR (NCI)
|
|
Mechanisms of Chromosomal Translocation
|
ZIA SC 010379
|
$289,223
|
$115,689
|
Aplan, Peter
|
CCR (NCI)
|
|
Genetic Predictors of AML Treatment Response
|
1R01CA133881-01A2
|
$674,105
|
$674,105
|
Aplenc, Richard
|
CHILDRENS HOSPITAL OF PHILADELPHIA
|
|
Adult Leukemia Research Center
|
5P01CA018029-35
|
$4,628,534
|
$4,628,534
|
APPELBAUM, FREDERICK
|
FRED HUTCHINSON CANCER RESEARCH CENTER
|
|
Mechanisms of PASG-Mediated Senescence in Hematopoietic Development and Leukemia
|
5R01CA120535-04
|
$311,600
|
$311,600
|
ARCECI, ROBERT
|
JOHNS HOPKINS UNIVERSITY
|
|
Regulation of the Expression of G[alpha]i2 by Reactive Oxygen Species
|
5SC1CA143985-02
|
|
$0
|
Arinze, Ifeanyi
|
MEHARRY MEDICAL COLLEGE
|
|
Molecular pathogenesis of MLL-AF4 leukemias
|
1R01CA140575-01A1
|
$355,690
|
$355,690
|
ARMSTRONG, SCOTT
|
CHILDREN'S HOSPITAL BOSTON
|
|
Long-term Treatment Related CNS Injury in Survivors of Childhood Cancer
|
1R21CA138988-01A2
|
$230,133
|
$230,133
|
Armstrong, Gregory
|
ST. JUDE CHILDREN'S RESEARCH HOSPITAL
|
|
Significance of Marrow Karyotypes in Inherited Bone Marrow Failure Syndromes
|
ZIA BC 010692
|
$71,905
|
$71,905
|
Arthur, Diane
|
CCR (NCI)
|
|
Cytogenetic Studies of B-cell Chronic Lymphocytic Leukemia (B-CLL)
|
ZIA SC 010282
|
$143,810
|
$143,810
|
Arthur, Diane
|
CCR (NCI)
|
|
Clinical Cancer Cytogenetics
|
ZID BC 010694
|
$503,334
|
$402,667
|
Arthur, Diane
|
CCR (NCI)
|
|
Oncogenic NOTCH Signaling
|
5P01CA119070-05
|
$1,028,373
|
$1,028,373
|
ASTER, JON
|
BRIGHAM AND WOMEN'S HOSPITAL
|
|
Southeast Cancer Control Consortium, Inc
|
2U10CA045808-24
|
$2,264,660
|
$22,647
|
ATKINS, JAMES
|
SOUTHEAST CANCER CONTROL CONSORTIUM
|
|
Eastern Cooperative Oncology Group
|
2U10CA080775-12
|
$104,956
|
$1,050
|
ATKINS, MICHAEL
|
BETH ISRAEL DEACONESS MEDICAL CENTER
|
|
Defining clinical efficacy and markers predicting response to bortezomib in AML
|
5K23CA118419-04
|
$143,370
|
$143,370
|
Attar, Eyal
|
MASSACHUSETTS GENERAL HOSPITAL
|
|
Eastern Cooperative Oncology Group Studies
|
2U10CA014548-36
|
$420,754
|
$4,208
|
AVERBOOK, BRUCE
|
CASE WESTERN RESERVE UNIVERSITY
|
|
Tyrosine kinase inhibitors for the treatment of childhood AML
|
1R01CA138744-01A1
|
$348,600
|
$348,600
|
BAKER, SHARYN
|
ST. JUDE CHILDREN'S RESEARCH HOSPITAL
|
|
Southwest Oncology Group Treatment Grant
|
2U10CA032102-31
|
$10,205,783
|
$204,116
|
BAKER, LAURENCE
|
UNIVERSITY OF MICHIGAN AT ANN ARBOR
|
|
Southwest Oncology Group Treatment Grant
|
3U10CA032102-31S2
|
$1,500,000
|
$30,000
|
BAKER, LAURENCE
|
UNIVERSITY OF MICHIGAN AT ANN ARBOR
|
Total relevant funding to Leukemia for this search: $239,689,242
|